Terasaki Innovation Summit

March 5 – 7, 2025 Abstract Requirements

Abstracts Must Conform with the Following Guidelines.

Important Dates:  

Abstract Deadline: Friday, January 31, 2025, 11:59 PM EDT

Notification Sent: Friday, February 7, 2025

Submission
•     When you have completed your abstract, please send it in PDF format to tis2025abstracts@terasaki.org.

Abstract and Poster Preparation:

•        Abstracts and Posters must be submitted and presented in English.

•        Character Limit: Abstracts and Posters are limited to 2,500 characters.  This includes the Title and text.

•        Titles: ALL CAPITAL LETTERS do not include authors or institutions, no period at the end, and no abbreviations.

•        Author Information: Authors will be printed in the order entered. Enter institutions including the following: department, institution, city, state/province, and country.

•        Abbreviations: A maximum of five (5) unique abbreviations are allowed within the body of the abstract.

•        Format: Abstracts of original work should be structured into the following four (4) content sections:

o       Aim

o       Methods

o       Results

o       Conclusions

Poster Formatting (Finish size: 48” H x 36” W)
•        Posters will be presented live during the morning and afternoon breaks on Wednesday, March 5, 2025, Thursday, March 6, 2025, and Friday, March 7, 2025, in the poster area of the Terasaki Institute: Woodland Hills, CA.

•        The following graphic formats will be supported: gif, png, tiff, tif, jpeg and jpg.

Publication
•        Abstracts will also be posted on the virtual platform on Terasaki.org up to one year after the Terasaki Innovation Summit Upon Author Approval.

•        Ensure that all co-authors approve of the abstract submission, publication, and potential presentation.

Contact Author
•    The presenting author will serve as the contact author and will be responsible for completing the disclosure information for all co-authors.  

Abstract Withdrawal
•        Abstracts cannot be withdrawn after Friday, January 31, 2025, 11:59 PM Eastern Time.  

•        To withdraw an abstract before Friday, January 31, 2025, please contact Stewart Han at shan@terasaki.org.

Abstract Review
•    Abstracts are blindly reviewed and graded by experts in the field.  They will be reviewed based on their clinical significance and scientific innovation.  Abstracts failing the criteria will not be accepted.

Website
•     The complete program and all selected abstracts will be posted on the Terasaki Institute website before the meeting.  Please note: Authors must agree to publish their submission online and, in the journal, to be considered for oral or poster presentation.  

Informed Consent
•    Any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1966: 14:103) and meet all the requirements governing informed consent of the country where the study was performed.  Any transplant procedures performed must meet the prevailing ethical standards.  

Use of Animals
•    All studies involving the use of animals must conform to the 1991 revision of "Guiding Principles in the Care and Use of Animals" (American Physiological Association).

Awards
•    Awards will be issued to the first author.  The first author is considered the lead researcher and/or takes primary responsibility for the abstract.  

o   Hisako Terasaki Young Innovator Award: $5000.00 awarded to the highest-ranked abstract. 

o   The winning poster will be recognized at the 2025 Terasaki Innovation Summit.

Changes to Abstracts After Submission
•     You can edit the abstract on the submission site up until the submission deadline of Friday, January 31, 2025.

Notification
•     Abstract notifications will be sent on Friday, February 7, 2025.  Abstracts will be accepted based on scientific and biomedical innovation and potential health impacts.